Published in Lancet on July 18, 1998
Association study of polymorphisms in LRP1, tau and 5-HTT genes and Alzheimer's disease in a sample of Colombian patients. J Neural Transm (Vienna) (2005) 0.81
Association at LRP gene locus with sporadic late-onset Alzheimer's disease. Lancet (1998) 1.53
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
Geographical relation between Alzheimer's disease and aluminum in drinking water. Lancet (1989) 4.57
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. J Virol (2002) 4.11
Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet (2001) 3.15
The effect of sodium chloride and temperature on the rate and extent of growth of Clostridium botulinum type A in pasteurized pork slurry. J Appl Bacteriol (1987) 2.91
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
Alzheimer's-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patients. Lancet (1994) 2.74
Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet (2005) 2.56
Prevalence rates of dementia in an ageing population: are low rates due to the use of insensitive instruments? Age Ageing (1990) 2.45
Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques. Nat Med (2000) 2.33
Improving doctor-patient communication in general practice. J R Coll Gen Pract (1976) 2.30
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics (1997) 2.28
THE PROLONGATION OF PENICILLIN RETENTION IN THE BODY BY MEANS OF PARA-AMINOHIPPURIC ACID. Science (1944) 2.19
Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med (2001) 2.10
Single-injection peribulbar local anaesthesia--a study of fifty consecutive cases. Aust N Z J Ophthalmol (1991) 2.09
Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology (2004) 2.05
Predicting microbial growth: the consequences of quantity of data. Int J Food Microbiol (1989) 2.01
The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. Hum Mol Genet (2005) 1.94
Vocational training and beyond--listening to voices from a void. Br J Gen Pract (1998) 1.86
A rapid method for preparing synaptosomes: comparison, with alternative procedures. Brain Res (1981) 1.85
Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet (1994) 1.77
A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients. Transplantation (1999) 1.62
Assessment of a DJ-1 (PARK7) polymorphism in Finnish PD. Neurology (2003) 1.59
Histochemical distribution of non-haem iron in the human brain. Acta Anat (Basel) (1992) 1.58
Risk factors in clinically diagnosed presenile dementia of the Alzheimer type: a case-control study in northern England. J Epidemiol Community Health (1995) 1.53
Genomic diversity correlates with clinical variation in Ph'-negative chronic myeloid leukaemia. Nature (1986) 1.53
Extended tracts of homozygosity identify novel candidate genes associated with late-onset Alzheimer's disease. Neurogenetics (2009) 1.50
Cutting needle biopsy in the diagnosis of clinically suspected non-carcinomatous disease of the lung. Br J Radiol (2000) 1.47
Common genetic variation near the connexin-43 gene is associated with resting heart rate in African Americans: a genome-wide association study of 13,372 participants. Heart Rhythm (2012) 1.43
Purification and characterization of two soluble Cl(-)-activated arginyl aminopeptidases from human brain and their endopeptidase action on neuropeptides. J Neurochem (1988) 1.41
No evidence of an association between the T16189C mtDNA variant and late onset dementia. J Med Genet (2004) 1.40
Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology (2007) 1.38
Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet (1986) 1.35
Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes. J Neurol Neurosurg Psychiatry (2007) 1.28
Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Ann N Y Acad Sci (1991) 1.24
The BCR gene recombines preferentially with Alu elements in complex BCR-ABL translocations of chronic myeloid leukaemia. Hum Mol Genet (1998) 1.23
Genome-wide meta-analyses of smoking behaviors in African Americans. Transl Psychiatry (2012) 1.23
Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies. Neurology (2000) 1.22
Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme. Neurochem Res (1997) 1.20
Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control. J Med Genet (2009) 1.19
Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome? Brain Pathol (1998) 1.17
Does the mitochondrial genome play a role in the etiology of Alzheimer's disease? Hum Genet (2006) 1.16
VARIATION AND MUTATION IN PENICILLIUM CHRYSOGENUM, WIS. Q176. J Bacteriol (1949) 1.15
Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection. Gut (2005) 1.11
Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease. Alzheimer Dis Assoc Disord (1993) 1.11
Telomeric association of chromosomes in B-cell lymphoid leukemia. Hum Genet (1984) 1.10
Case-Control study of the extended tau gene haplotype in Parkinson's disease. Ann Neurol (2001) 1.09
Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience (1995) 1.08
Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementia. Neuropathol Appl Neurobiol (2006) 1.08
Agonal status affects the metabolic activity of nerve endings isolated from postmortem human brain. Neurochem Pathol (1985) 1.03
Expression of putative sex-determining genes during the thermosensitive period of gonad development in the snapping turtle, Chelydra serpentina. Sex Dev (2007) 1.02
The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease. Int J Geriatr Psychiatry (2001) 1.02
Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use. Neuroscience (1998) 1.02
Exome sequencing: an efficient diagnostic tool for complex neurodegenerative disorders. Eur J Neurol (2012) 1.01
Effects of nicotine gum on repeated administration of the Stroop test. Psychopharmacology (Berl) (1991) 1.00
Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients. Biochem J (1992) 0.99
Matching-to-sample deficits in patients with senile dementias of the Alzheimer and Lewy body types. Arch Neurol (1992) 0.99
Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease. Neurosci Lett (2000) 0.99
Metabolically active synaptosomes can be prepared from frozen rat and human brain. J Neurochem (1983) 0.99
Transfected synphilin-1 forms cytoplasmic inclusions in HEK293 cells. Brain Res Mol Brain Res (2001) 0.98
Complex chromosomal translocations in the Philadelphia chromosome leukemias. Serial translocations or a concerted genomic rearrangement? Cancer Genet Cytogenet (1991) 0.98
The pituitary-adrenal system of the genetically obese (ob/ob) mouse. J Endocrinol (1975) 0.97
Context-dependent cocaine sensitization: differential effect of haloperidol on development versus expression. Pharmacol Biochem Behav (1989) 0.97
Uptake and distribution of iron and transferrin in the adult rat brain. J Neurochem (1992) 0.97
Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatry (1987) 0.96
Identification of regions that regulate the expression and activity of G protein-gated inward rectifier K+ channels in Xenopus oocytes. J Physiol (1997) 0.96
General practice. Drawing young blood. Health Serv J (1997) 0.96
Gastrointestinal absorption of aluminium in Alzheimer's disease: response to aluminium citrate. Age Ageing (1992) 0.96
SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. Neurology (2004) 0.95
Association of tau haplotype-tagging polymorphisms with Parkinson's disease in diverse ethnic Parkinson's disease cohorts. Neurodegener Dis (2006) 0.94
Antibodies to thaumatin as a model of the sweet taste receptor. Nature (1978) 0.94
Chronic postnatal DE-71 exposure: effects on learning, attention and thyroxine levels. Neurotoxicol Teratol (2008) 0.94
Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians. Neurosci Lett (1995) 0.94
Mitochondrial dysfunction in Parkinson's disease. Parkinsons Dis (2011) 0.93
Longitudinal bone mineral density changes in early rheumatoid arthritis. Br J Rheumatol (1994) 0.93
Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD. Neurology (2000) 0.92
Neuropathological diagnoses in elderly patients in Oslo: Alzheimer's disease, Lewy body disease, vascular lesions. Dementia (1995) 0.92
Polymerase chain reaction for detection of Clostridium botulinum types A, B and E in food, soil and infant faeces. J Appl Bacteriol (1994) 0.92
Alzheimer's disease and the relationship between silicon and aluminium in water supplies in northern England. J Epidemiol Community Health (1995) 0.92
Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation. J Neurol Neurosurg Psychiatry (2005) 0.91
Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord (2001) 0.91
Cognitive restructuring treatment: a controlled trail with anxious patients. Behav Res Ther (1980) 0.90
Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Abeta42 secretion. Hum Mol Genet (1999) 0.90
Application of PCR to a clinical and environmental investigation of a case of equine botulism. J Clin Microbiol (1994) 0.90
Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias. Arch Neurol (1999) 0.90
Influence of the amyloid precursor protein locus on dementia in Down syndrome. Neurology (2004) 0.90
Screening for LRRK2 mutations in patients with Parkinson's disease in Russia: identification of a novel LRRK2 variant. Eur J Neurol (2008) 0.90
Gastrointestinal absorption of aluminum is increased in Down's syndrome. Biol Psychiatry (1997) 0.89
Testing association between LRRK2 and Parkinson's disease and investigating linkage disequilibrium. J Med Genet (2006) 0.89